Education
About Us
Working with TipRanks
Follow Us
Axsome Therapeutics Inc. (AXSM)
:AXSM
AXSM Analyst Ratings
Strong Buy
16 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AXSM Stock 12 Month Forecast
Average Price Target
$169.71
▲(43.20% Upside)
| Highest Price Target$200.00 | Average Price Target$169.71 | Lowest Price Target$144.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$180
Buy
51.89%
Upside
Reiterated
08/22/25
Positive Outlook for Axsome Therapeutics Amidst SYMBRAVO's Market Expansion and Patent StrengthValuation and Risks. Our Buy rating and $180 price target are based on a discounted cash flow (DCF)-based analysis. We apply a 10% discount rate to all future cash flows along with a 28.1% effective tax rate and a ~16% sales and marketing offset rate. This yields a total firm value of ~$10.8B, or a price per share of $180 given ~60.4M fully diluted shares outstanding as of mid-2026.
Mizuho Securities
$200
Buy
68.76%
Upside
Reiterated
08/21/25
TR | OpenAI - 4o
$114→$116
Hold
-2.12%
Downside
Reiterated
08/21/25
RBC Capital
$189
Buy
59.48%
Upside
Reiterated
08/20/25
Needham
$150
Buy
26.57%
Upside
Reiterated
08/11/25
UBS
$151→$144
Buy
21.51%
Upside
Reiterated
08/06/25
William Blair
―
Buy
―
Reiterated
08/04/25
Leerink Partners
$150
Buy
26.57%
Upside
Reiterated
08/04/25
Bank of America Securities
$173→$176
Buy
48.51%
Upside
Reiterated
08/04/25
Morgan Stanley
$190→$191
Buy
61.17%
Upside
Reiterated
08/04/25
Wells Fargo
$165
Buy
39.23%
Upside
Reiterated
08/04/25
TD Cowen
$190
Buy
60.32%
Upside
Reiterated
08/04/25
Oppenheimer
$183
Buy
54.42%
Upside
Reiterated
07/31/25
Piper Sandler
$148
Buy
24.88%
Upside
Reiterated
07/29/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$180
Buy
51.89%
Upside
Reiterated
08/22/25
Positive Outlook for Axsome Therapeutics Amidst SYMBRAVO's Market Expansion and Patent StrengthValuation and Risks. Our Buy rating and $180 price target are based on a discounted cash flow (DCF)-based analysis. We apply a 10% discount rate to all future cash flows along with a 28.1% effective tax rate and a ~16% sales and marketing offset rate. This yields a total firm value of ~$10.8B, or a price per share of $180 given ~60.4M fully diluted shares outstanding as of mid-2026.
Mizuho Securities
$200
Buy
68.76%
Upside
Reiterated
08/21/25
TR | OpenAI - 4o
$114→$116
Hold
-2.12%
Downside
Reiterated
08/21/25
RBC Capital
$189
Buy
59.48%
Upside
Reiterated
08/20/25
Needham
$150
Buy
26.57%
Upside
Reiterated
08/11/25
UBS
$151→$144
Buy
21.51%
Upside
Reiterated
08/06/25
William Blair
―
Buy
―
Reiterated
08/04/25
Leerink Partners
$150
Buy
26.57%
Upside
Reiterated
08/04/25
Bank of America Securities
$173→$176
Buy
48.51%
Upside
Reiterated
08/04/25
Morgan Stanley
$190→$191
Buy
61.17%
Upside
Reiterated
08/04/25
Wells Fargo
$165
Buy
39.23%
Upside
Reiterated
08/04/25
TD Cowen
$190
Buy
60.32%
Upside
Reiterated
08/04/25
Oppenheimer
$183
Buy
54.42%
Upside
Reiterated
07/31/25
Piper Sandler
$148
Buy
24.88%
Upside
Reiterated
07/29/25
Best Analysts Covering Axsome Therapeutics
1 Month
xxx
Success Rate
18/29 ratings generated profit
Average Return
+13.56%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 62.07% of your transactions generating a profit, with an average return of +13.56% per trade.
3 Months
xxx
Success Rate
17/24 ratings generated profit
Average Return
+13.08%
reiterated a xxx
rating 19 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.83% of your transactions generating a profit, with an average return of +13.08% per trade.
1 Year
Success Rate
18/19 ratings generated profit
Average Return
+25.68%
reiterated a buy rating 4 days ago
Copying Leonid Timashev's trades and holding each position for 1 Year would result in 94.74% of your transactions generating a profit, with an average return of +25.68% per trade.
2 Years
xxx
Success Rate
34/35 ratings generated profit
Average Return
+40.88%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 97.14% of your transactions generating a profit, with an average return of +40.88% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AXSM Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
24
33
38
41
37
Buy
53
30
20
20
20
Hold
3
7
12
12
12
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
80
71
71
74
69
Each month's total comprises the sum of three months' worth of ratings.
AXSM Financial Forecast
AXSM Stock Forecast FAQ
What is AXSM’s average 12-month price target, according to analysts?
Based on analyst ratings, Axsome Therapeutics Inc.’s 12-month average price target is 169.71.
What is AXSM’s upside potential, based on the analysts’ average price target?
Axsome Therapeutics Inc. has 43.20% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AXSM a Buy, Sell or Hold?
Axsome Therapeutics Inc. has a consensus rating of Strong Buy which is based on 16 buy ratings, 0 hold ratings and 0 sell ratings.
What is Axsome Therapeutics Inc.’s price target?
The average price target for Axsome Therapeutics Inc. is 169.71. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $200.00 ,the lowest forecast is $144.00. The average price target represents 43.20% Increase from the current price of $118.51.
The highest analyst price target is $200.00 ,the lowest forecast is $144.00. The average price target represents 43.20% Increase from the current price of $118.51.
What do analysts say about Axsome Therapeutics Inc.?
Axsome Therapeutics Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of AXSM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.